Bausch + Lomb Corp

NYSE:BLCO   4:00:00 PM EDT
18.88
-0.18 (-0.94%)
7:12:27 PM EDT: $18.96 +0.08 (+0.42%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)6.64B
Current PEN/A
Forward PE 31.47
2yr Forward PE 21.95
See more stats
Estimates Current Quarter
Revenue$1.17 Billion
Adjusted EPS$0.16
See more estimates
10-Day MA$18.91
50-Day MA$16.96
200-Day MA$15.78
See more pivots

Bausch + Lomb Corp Stock, NYSE:BLCO

520 Applewood Crescent, Vaughan, Ontario L4K 4B4
Canada
Phone: +1.905.695.7700
Number of Employees: 13300

Description

Bausch + Lomb Corp. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company operates its business through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals and Surgical. The Vision Care/Consumer Health Care segment includes both contact lens and consumer eye care businesses. The Ophthalmic Pharmaceuticals segment consists of a broad line of proprietary pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. The Surgical segment consists of medical device equipment, consumables and instrumental tools and technologies for the treatment of corneal, cataracts, and vitreous and retinal eye conditions, and includes IOLs and delivery systems, phacoemulsification equipment and other surgical instruments and devices necessary for cataract surgery. Bausch + Lomb was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Vaughan, Canada.